Browse Category

BSE:524816 News 1 December 2025

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Mumbai, 1 December 2025 — Natco Pharma Limited (NSE: NATCOPHARM, BSE: 524816) is back in the spotlight. The stock is seeing heavy trading, fresh institutional interest and a sharp intraday bounce, even as investors digest softer Q2 FY26 earnings, a recent USFDA inspection in Chennai and a large acquisition in South Africa. Natco Pharma share price today: sharp bounce with…

Stock Market Today

  • Rexel S.A. (RXL.PA) Trades at €37.58 Pre-Earnings with Key Metrics in Focus
    February 6, 2026, 1:53 PM EST. Rexel S.A. stock (RXL.PA) trades at €37.58 after hours ahead of earnings due on Feb 11, 2026. Investors eye operating margin (~3.99%), EPS (€0.83), and revenue per share (€65.66). The firm holds a high PE ratio of 45.19, reflecting elevated expectations. Meyka AI assigns a B+ rating (73.58/100) and technical indicators show a neutral trend. The company's leverage is notable with net debt to EBITDA at 3.7, raising balance sheet scrutiny. Risks include margin pressure and weak industrial demand from last year's negative EPS growth. Meyka AI projects a near-term price dip but suggests a longer-term upside of nearly 10%. Rexel's dividend yield is 3.2%, and cash flow generation remains steady. Market focus will be on margin recovery and free cash flow guidance during the earnings release.
Go toTop